Youlong L. Wang
Sanya, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.
Journal: Annals of neurology
Published: December 28, 2025
IL-6 receptor blockade impedes proinflammatory atypical Treg subset associated with immune checkpoint inhibitor-induced inflammatory arthritis.
Journal: The Journal of clinical investigation
Published: September 24, 2025
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity.
Journal: Cell reports. Medicine
Published: July 09, 2025
Brain metabolic vulnerability in 18-F FDG PET/CT predict future depression risk in young cancer survivors.
Journal: Translational psychiatry
Published: May 07, 2025
Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy.
Journal: Breast cancer research : BCR
Published: December 10, 2024
Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients.
Journal: Frontiers in immunology
Published: December 05, 2024
Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment.
Journal: Frontiers in oncology
Published: January 25, 2024
Cerebral 18F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 16, 2023
Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis.
Journal: Frontiers in immunology
Published: December 22, 2022
Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination.
Journal: Frontiers in immunology
Published: November 29, 2022
Multicenter real world study on the efficacy and safety of eribulin for the treatment of advanced breast cancer
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 21, 2022
Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers.
Journal: Frontiers in medicine
Published: March 17, 2022
Last Updated: 09/26/2026